Pancreatic Cancer Research

ResearcherUniversity of Wisconsin–MadisonActive in the last 2 years

Jacob S. Witt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5891-8055; OpenAlex author ID A5043178905. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patients With Resectable Pancreatic Cancer: Su… First author DOI 10.1016/j.prro.2025.01.011↗
  2. A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2020.09.010↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Frederick Bassetti · 2 shared papers, 2021–2025 · strength 0.31
  2. Sean M. Ronnekleiv‐Kelly · 2 shared papers, 2021–2025 · strength 0.31
  3. Noelle K. LoConte · 2 shared papers, 2021–2025 · strength 0.31
  4. Daniel Erik Abbott · 2 shared papers, 2021–2025 · strength 0.31
  5. Sharon Marie Weber · 2 shared papers, 2021–2025 · strength 0.31
  6. Nataliya Volodymyrivna Uboha · 2 shared papers, 2021–2025 · strength 0.31
  7. Jeremy D. Kratz · 1 shared paper, 2025 · strength 0.20
  8. Mustafa M. Basree · 1 shared paper, 2025 · strength 0.20
  9. Syed Nabeel Zafar · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.